All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
04/11/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	3
04/04/22	4	Statement of changes in beneficial ownership of securities	2
04/04/22	4	Statement of changes in beneficial ownership of securities	2
04/04/22	4	Statement of changes in beneficial ownership of securities	2
04/04/22	4	Statement of changes in beneficial ownership of securities	2
03/15/22	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5.1 EX-23.2 EX-FILING FEES	12
03/15/22	10-K	Annual report pursuant to Section 13 and 15(d) Documents EX-4.1 EX-10.10 EX-10.11 EX-10.12 EX-23.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	165
03/08/22	8-K	Current report filing	3
02/17/22	4	Statement of changes in beneficial ownership of securities	2
02/17/22	4	Statement of changes in beneficial ownership of securities	2